Name : Ayappa Selva Pille(27Y/M)

Date : 16 Mar 2025

Test Asked : Hi Balic 10 Rbs Mer Ecg

Report Status: Complete Report

PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF
6145099068 BAJAJ MER , ROOM NO. 3063
TEST ASKED : HI BALIC 10 RBS MER ECG GHADGE NAGAR, KB ROAD AMBARNATH WEST,
BEHIND BUDDHAVIHAR, , ,421501

Report Availability Summary

Note: Please refer to the table below for status of your tests.

14 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

HI BALIC 10 RBS MER ECG Ready

RANDOM BLOOD SUGAR(GLUCOSE) Ready

ERYTHROCYTE SEDIMENTATION RATE (ESR) Ready

HEMOGRAM - 6 PART (DIFF) Ready

CREATININE - SERUM Ready

HbA1c Ready

HEPATITIS B SURFACE ANTIGEN(HBSAG) RAPID TEST Ready

URIC ACID Ready

LIPID PROFILE Ready

COMPLETE URINE ANALYSIS Ready

BLOOD UREA NITROGEN (BUN) Ready

LIVER FUNCTION TESTS Ready

ELECTROCARDIOGRAM Ready

HIV I and II Ready

MEDICAL EXAMINATION REPORT Ready

PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063 GHADGE
TEST ASKED : HI BALIC 10 RBS MER ECG NAGAR, KB ROAD AMBARNATH WEST, BEHIND
BUDDHAVIHAR, , ,421501

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
EOSINOPHILS 8 % 1-6
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 34.6 pq 27.0-32.0
MEAN CORPUSCULAR VOLUME(MCV) 105.9 fL 83.0-101.0
PLATELET DISTRIBUTION WIDTH(PDW) 9.4 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 19.4 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 51.9 fL 39-46
TOTAL RBC 4.37 X 10^6/µL 4.5-5.5
COMPLETE URINE ANALYSIS
URINE BLOOD PRESENT - Absent
LIPID
HDL CHOLESTEROL - DIRECT 33 mg/dL 40-60
LIVER
BILIRUBIN (INDIRECT) 1.17 mg/dL 0-0.9
BILIRUBIN - TOTAL 1.5 mg/dL 0.3-1.2
BILIRUBIN -DIRECT 0.33 mg/dL < 0.3
RENAL
CREATININE - SERUM 0.65 mg/dL 0.72-1.18

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY 6145099068 BAJAJ MER , ROOM NO. 3063
: SELF
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG BEHIND BUDDHAVIHAR, , ,421501

PATIENTID : AP26008001
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 5 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 97 mg/dL

Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:39

Report Released on (RRT) : 16 Mar 2025 18:25
Sample Type : EDTA Whole Blood
Labcode : 1603000749/DK495 Dr Renuka MD(Path) Dr Arshiya MD(Path)
Barcode : DM635401
Page : 1 of 13
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG
BEHIND BUDDHAVIHAR, , ,421501

TEST NAME TECHNOLOGY VALUE UNITS

ERYTHROCYTE SEDIMENTATION RATE (ESR) MODIFIED WESTERGREN 4 mm / hr
Bio. Ref. Interval. :-

Male : 0-15 Female : 0-20

Clinical Significance:
- An erythrocyte sedimentation rate (ESR) is a blood test that can rise if you have inflammation in your
body. Its also used as a marker to monitor prognosis of an existing inflammatory/infective condition.
- Inflammation is your immune systems response to injury, infection, and many types of conditions,
including immune system disorders, certain cancers and blood disorders.
- A high ESR test result may be from a condition that causes inflammation, such as: Arteritis, Arthritis,
Systemic vasculitis, Polymyalgia rheumatica, Inflammatory bowel disease, Kidney disease, Infections like
Tuberculosis etc, Rheumatoid arthritis and other autoimmune diseases, Heart disease, Certain cancers and
many other Conditions.
- A low ESR test result may be caused by conditions such as: A blood disorder, such as: Polycythemia, Sickle
cell disease (SCD), Leukocytosis, Heart failure, Certain kidney and liver problems etc.
- Certain physiological conditions also affect ESR results, these include : Pregnancy, menstrual cycle,
ageing, obesity, drinking alcohol regularly, and exercise, Certain medicines and supplements also can
affect ESR results.
- Hence Its always suggested to interpret ESR results in conjunction with Clinical History and other
findings.

References :
https://medlineplus.gov/lab-tests/erythrocyte-sedimentation-rate-esr/

Please correlate with clinical conditions.

Method:- MODIFIED WESTERGREN

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:39
Report Released on (RRT) : 16 Mar 2025 18:25
Sample Type : EDTA Whole Blood
Dr Renuka MD(Path) Dr Arshiya MD(Path)
Labcode : 1603000749/DK495
Barcode : DM635401 Page : 2 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063 GHADGE
NAGAR, KB ROAD AMBARNATH WEST, BEHIND
TEST ASKED : HI BALIC 10 RBS MER ECG
BUDDHAVIHAR, , ,421501

PATIENTID : AP26008001

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 15.1 g/dL 13.0-17.0
Hematocrit (PCV) CPH Detection 46.3 % 40.0-50.0
Total RBC HF & EI 4.37 X 10^6/µL 4.5-5.5
Mean Corpuscular Volume (MCV) Calculated 105.9 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 34.6 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 32.6 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 51.9 fL 39-46
Red Cell Distribution Width (RDW - CV) Calculated 13.3 % 11.6-14
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 322.3 - *Refer Note below
MENTZER INDEX Calculated 24.2 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 5.78 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 51.4 % 40-80
Lymphocytes Percentage Flow Cytometry 36.5 % 20-40
Monocytes Percentage Flow Cytometry 3.6 % 2-10
Eosinophils Percentage Flow Cytometry 8 % 1-6
Basophils Percentage Flow Cytometry 0.3 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.2 % 0-0.5
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 2.97 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.11 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.21 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.02 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.46 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.01 X 10³ / µL 0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 314 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 9.4 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 9.4 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 19.4 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.3 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with macrocytes & ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:39

Report Released on (RRT) : 16 Mar 2025 18:25

Sample Type : EDTA Whole Blood
Labcode : 1603000749/DK495 Dr Renuka MD(Path) Dr Arshiya MD(Path)
Barcode : DM635401 Page : 3 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063 GHADGE
TEST ASKED HI BALIC 10 RBS MER ECG NAGAR, KB ROAD AMBARNATH WEST, BEHIND
:
BUDDHAVIHAR, , ,421501
PATIENTID : AP26008001

TEST NAME TECHNOLOGY VALUE UNITS INTERPRETATION

HIV I and II E.C.L.I.A 0.19 OD ratio NEGATIVE

Non Reactive : < 1
Reactive: >=1

Clinical Significance
HIV is a screening test being performed as per NACO guidelines. The kits utilize a mixture of recombinant
proteins for detection of antibodies to all subtypes of HIV-1 and HIV-2 in human serum or plasma. A positive
report does not confirm diagnosis of HIV infection at any point of time and all positive cases should be
confirmed by confirmatory test like western blot or PCR. Similarly, a non-reactive test doesnt exclude the
possibility of HIV infection and must be interpreted by a medical practitioner in light of the exposure and
possible window period.

Specifications:
Precision: Intra-Assay (%CV) :5.90%, Inter-Assay (%CV):4.50%, Sensitivity : 100%, Specificity :100%

Kid validation reference : Proposal for the validation of Anti HIV 1/2 or HIV Ag/Ab combination Assays Anti HCV
Assays HBsAg and Anti HBc assay for Use with cadaveric Samples PEI 08/05/2014.

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Labcode : 1603000851/DK495 Dr Renuka MD(Path) Dr Arshiya MD(Path)
Barcode : DT326301
Page : 4 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY 6145099068 BAJAJ MER , ROOM NO. 3063 GHADGE
: SELF
NAGAR, KB ROAD AMBARNATH WEST, BEHIND
TEST ASKED : HI BALIC 10 RBS MER ECG BUDDHAVIHAR, , ,421501

PATIENTID : AP26008001
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 113 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 33 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 68 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 60 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.4 Ratio 3-5
TRIG / HDL RATIO CALCULATED 1.81 Ratio < 3.12
LDL / HDL RATIO CALCULATED 2.1 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.48 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 80.02 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 11.96 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Labcode : 1603000851/DK495 Dr Renuka MD(Path) Dr Arshiya MD(Path)

Barcode : DT326301 Page : 5 of 13

PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY 6145099068 BAJAJ MER , ROOM NO. 3063 GHADGE
: SELF
NAGAR, KB ROAD AMBARNATH WEST, BEHIND
TEST ASKED : HI BALIC 10 RBS MER ECG BUDDHAVIHAR, , ,421501

PATIENTID : AP26008001
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
ALKALINE PHOSPHATASE PHOTOMETRY 50.9 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 1.5 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.33 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 1.17 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 24.6 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 19.7 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 15 U/L < 45
SGOT / SGPT RATIO CALCULATED 1.31 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.14 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.27 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.87 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.49 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Labcode : 1603000851/DK495 Dr Renuka MD(Path) Dr Arshiya MD(Path)

Barcode : DT326301 Page : 6 of 13

PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG
BEHIND BUDDHAVIHAR, , ,421501

TEST NAME TECHNOLOGY VALUE

HEPATITIS B SURFACE ANTIGEN(HBSAG) RAPID TEST IMMUNOASSAY NON REACTIVE

NONREACTIVE : Indicates absence of Hepatitis B viral surface antigen

REACTIVE : Indicates presence of Hepatitis B viral surface antigen

Clinical Significance :
1. This is a screening and qualitative test and a positive report does not confirm diagnosis. All Reactive tests should be confirmed
with HBV DNA PCR and other laboratory methods, as per National guidelines.
2. The test should always be evaluated with other data available to the physician.
3. False Reactive tests can be observed in patients receiving Mouse monoclonal antibodies, Biotin therapy and due to presence of
heterophile antibodies in serum.
4. False Non reactive results can be obtained if sample collected in early course of disease.

Sensitivity : 100% , Specificity : 100%

References: VollerA, Bartlett A, and Bidwell D. Zuckermann AJ: Viral Hepatitis with special reference to hepatitis B immunoassays
for the 80s. eds University Park Press.1981;361-373. National Laboratory guidelines for viral Hepatitis.

Please correlate with clinical conditions.

Method:- RAPID IMMUNOCHROMATOGRAPHIC ASSAY

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Dr Renuka MD(Path) Dr Arshiya MD(Path)
Labcode : 1603000851/DK495
Barcode : DT326301 Page : 7 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY 6145099068 BAJAJ MER , ROOM NO. 3063 GHADGE
: SELF
NAGAR, KB ROAD AMBARNATH WEST, BEHIND
TEST ASKED : HI BALIC 10 RBS MER ECG BUDDHAVIHAR, , ,421501

PATIENTID : AP26008001
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.51 mg/dL 7.94 - 20.07
UREA / SR.CREATININE RATIO CALCULATED 31.31 Ratio < 52
UREA (CALCULATED) CALCULATED 20.35 mg/dL Adult : 17-43
BUN / Sr.CREATININE RATIO CALCULATED 14.63 Ratio 9:1-23:1
URIC ACID PHOTOMETRY 4.6 mg/dL 4.2 - 7.3
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
UR/CR - Derived from UREA and Sr.Creatinine values.
UREAC - Derived from BUN Value.
B/CR - Derived from serum Bun and Creatinine values
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Labcode : 1603000851/DK495 Dr Renuka MD(Path) Dr Arshiya MD(Path)

Barcode : DT326301 Page : 8 of 13

PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG
BEHIND BUDDHAVIHAR, , ,421501

TEST NAME TECHNOLOGY VALUE UNITS

CREATININE - SERUM PHOTOMETRY 0.65 mg/dL
Bio. Ref. Interval. :-

Male : 0.72 -1.18 mg/dL

Female: 0.55 - 1.02 mg/dL

Clinical Significance :
The significance of a single creatinine value must be interpreted in light of the patients muscle mass. A patient with a greater
muscle mass will have a higher creatinine concentration. The trend of serum creatinine concentrations over time is more important
than absolute creatinine concentration. Serum creatinine concentrations may increase when an ACE inhibitor (ACEI) is taken. The
assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic.

Please correlate with clinical conditions.

Method:- Creatinine Enzymatic Method

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Dr Renuka MD(Path) Dr Arshiya MD(Path)
Labcode : 1603000851/DK495
Barcode : DT326301 Page : 9 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG
BEHIND BUDDHAVIHAR, , ,421501

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 132 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:47
Report Released on (RRT) : 16 Mar 2025 21:31
Sample Type : SERUM
Dr Renuka MD(Path) Dr Arshiya MD(Path)
Labcode : 1603000851/DK495
Barcode : DT326301 Page : 10 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

6145099068 BAJAJ MER , ROOM NO. 3063
REF. BY : SELF
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG BEHIND BUDDHAVIHAR, , ,421501

PATIENTID : AP26008001
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.
Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.02 - 1.003-1.030
PH pH indicator 6 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction PRESENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy 3 cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy 3 cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 16:48
Report Released on (RRT) : 16 Mar 2025 18:55
Sample Type : URINE
Dr Renuka MD(Path) Dr Arshiya MD(Path)
Labcode : 1603094296/DK495
Barcode : DE476626 Page : 11 of 13
PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703

NAME : AYAPPA SELVA PILLE(27Y/M) HOME COLLECTION :

REF. BY : SELF 6145099068 BAJAJ MER , ROOM NO. 3063
GHADGE NAGAR, KB ROAD AMBARNATH WEST,
TEST ASKED : HI BALIC 10 RBS MER ECG
BEHIND BUDDHAVIHAR, , ,421501

TEST NAME TECHNOLOGY VALUE UNITS

RANDOM BLOOD SUGAR(GLUCOSE) PHOTOMETRY 99.86 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Random/Post-Prandial Plasma

Glucose (RPG/PPPG)

Normal 70 to 140 mg/dl

Impaired Glucose 140 - 199 mg/dl

Tolerance

Diabetes Greater than or Equal to 200

mg/dl
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

~~ End of report ~~

Sample Collected on (SCT) : 16 Mar 2025 09:20

Sample Received on (SRT) : 16 Mar 2025 15:30
Report Released on (RRT) : 16 Mar 2025 19:40
Sample Type : FLUORIDE PLASMA
Dr Renuka MD(Path) Dr Arshiya MD(Path)
Labcode : 1603088429/DK495
Barcode : DT192601 Page : 12 of 13
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
 Date: IST: 2025-03-16 09:29:32 Report ID: I2HM_01Q82T7C73R0QBN_V73R0QD8
Personal Details | Pre-Existing Medical- | Symptoms | Vitals | Measurements | Interpretation
Interpretation(Unconfirmed)
UHID: 01Q82T7C73R0QBN | Conditions | | | HR: 74 BPM | Normal Sinus Rhythm
PatientID: | | | | PR: 159 ms | Normal Axis
Normal Sinus Rhythm
Name: Ayappa selva pille | | | | PD: 118 ms | Normal axis
DOB: 01/19/1998 | | | | QRSD: 83 ms |
Age: 27 | | | | QRS Axis: 85 deg |
Gender: Male | | | | QT/QTc: 361/401 ms |
Mobile: 7719039821 | | | | |
| | | | |
| | | | |
This trace is generated by KardioScreen; Cloud-Connected, Portable, Digital, 6-12 Lead Scalable ECG Platform from IMEDRIX

I aVR V1 V4

II aVL V2 V5

III aVF V3 V6

II

Speed: 25 mm/sec F: 0.05 - 40 Hz Limb: 10 mm/mV Chest: 10 mm/mV

Disclaimer: ECG plot for inference by qualified Medical Practitioners only Version-1.9 Copyright iMedrix, All Rights Reserved
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at [email protected]
or call us on 022-3090 0000

+ T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 13 of 13